Submission Details
| 510(k) Number | K883991 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 20, 1988 |
| Decision Date | October 12, 1988 |
| Days to Decision | 22 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | — |
K883991 is an FDA 510(k) clearance for the KVM HEMOGLOBIN LYSING REAGENT, a Products, Red-cell Lysing Products (Class I — General Controls, product code GGK), submitted by Kvm Technologies, Inc. (Houston, US). The FDA issued a Cleared decision on October 12, 1988, 22 days after receiving the submission on September 20, 1988. This device falls under the Hematology review panel. Regulated under 21 CFR 864.8540.
| 510(k) Number | K883991 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 20, 1988 |
| Decision Date | October 12, 1988 |
| Days to Decision | 22 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | — |
| Product Code | GGK — Products, Red-cell Lysing Products |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 864.8540 |